Faisal Bakaeen, MD, provides an update on Cleveland Clinic Heart, Vascular and Thoracic Institute Coronary Artery Disease Center's 2022 results.

2022 Coronary Artery Disease Results

In 2020, same day discharge and next day discharge accounted for 22.1 percent (n = 114 of 516) and 63.8 percent (n = 329 of 516) of outpatient TF-TAVR. Samir Kapadia, MD, Chairman of Cardiology, and Amar Krishnaswamy, MD, Head of Interventional Cardiology, discuss discharge planning considerations for patients having TAVR and the benefit of same day discharge if appropriate.

The Evolution to Same Day Discharge After TAVR

Eric Roselli, MD, provides an update on Cleveland Clinic Heart, Vascular and Thoracic Institute Aorta Center's 2022 results.

2022 Aorta Center Results

A Cleveland Clinic-led trial found that testosterone-replacement therapy did not result in a higher incidence of major adverse cardiac events in middle-aged and older men with hypogonadism (also known as low testosterone) who also had preexisting or a high risk of cardiovascular disease. However, researchers still urge caution when considering testosterone therapy. Dr. Steve Nissen discusses the results of the TRAVERSE trial.

Testosterone Replacement Therapy in Patients with Low Testosterone: Findings from TRAVERSE Trial

Daniel Burns, MD, provides an update on 2022's valve results. Learn more: https://my.clevelandclinic.org/departments/heart/depts/valve-center

Daniel Burns, MD, provides an update on 2022's valve results. <br>Learn more: <a href="https://my.clevelandclinic.org/departments/heart/depts/valve-center" rel="nofollow" target="_blank">https://my.clevelandclinic.org/departments/heart/depts/valve-center</a>

2022 Valve Results

Thomas Callahan, MD, electrophysiologist and Co-Director, Lead Extraction Program, discusses the incidence of sudden cardiac death in athletic populations. Dr. Callahan reviews how often SCD occurs in athletes, the etiology and survival, drawing from studies in the US, Canada, the United Kingdom and France.

Incidence of Sudden Cardiac Death in Athletes

Aortopathies can have implications for patients who are athletes. Sagar Kalahasti, MD, Director of the Marfan Syndrome and Connective Tissue Disorder Clinic and member of the Aorta Center, discusses etiologies and evaluation of aortopathies in the athletic heart.

A Review of Aortopathies in Athletes

Cleveland Clinic is dedicated to providing a world-class experience to students, residents, and fellows. Frank Caputo, MD, Program Director of the Vascular Surgery Training Programs and staff vascular surgeon in the Sydell and Arnold Miller Family Heart, Vascular and Thoracic Institute, highlights benefits of the vascular surgery program, including tools, opportunities and leadership roles.

Vascular Surgery Training Programs

Life after a cardiac event can be difficult for patients to adjust to, especially for athletes. The decision to return to play is important and must be made by weighing the risks and benefits for each person. Michael Emery, MD, Co-Director of the Sports Cardiology Center, talks about considerations for return to play and the shared decision-making process.

Return to Play: A Cardiac Event Doesn't Always Mean the End

Ayman Hussein, MD, discusses single shot ablation using radiofrequency.

Global EP Summit: AF Ablation

A Cleveland Clinic podcast exploring heart, vascular and thoracic topics of interest to healthcare providers: medical and surgical treatments, diagnostic testing, medical conditions, and research, technology and practice issues.

Cardiac Consult: A Cleveland Clinic Podcast for Healthcare Professionals

Dr. Steven Nissen, Chairman of the Robert and Suzanne Tomsich Department of Cardiovascular Medicine at Cleveland Clinic discusses hypertrophic cardiomyopathy (HCM) with experts: cardiologist Milind Desai, MD and cardiovascular surgeon, Nicholas Smedira, MD .  Topics include diagnostic findings, the nuances of surgical approach, determining the appropriate treatment for the best outcomes including symptom relief and decreased incidence of cardiac death, and genetic screening.

Hypertrophic Cardiomyopathy

Dr. Steven Nissen discusses talks with Jerry Estep, MD, Section Head, Heart Failure and Transplantation and Edward Soltesz, MD, Surgical Director of the Kaufman Center for Heart Failure and Recovery about innovations in heart failure surgery, including changes in LVAD therapy and heart transplant making an impact on patient outcomes, when patients should be referred for advanced heart failure therapy, LVAD back-up strategies for traditional cardiac surgery, the newest medications and when to prescribe, and the new technologies for pulmonary pressure monitoring.

Heart Failure Strategies: What’s new?

Dr. Lee Kirksey, Vascular Surgeon and Vice Chairman of Vascular Surgery is joined by Dr. Umesh Khot, Section Head Section Head, Regional Cardiology and Director of Quality in the Heart and Vascular Institute and patient Herb Pleasant to talk about health care disparities.  Together they cover issues related to minority and lower socio-economic disparities and the need to develop trust in the health care system to initiate care.  It is important to identify risk factors earlier in life, establish a diagnosis and treatment plan, and find a doctor who is willing to work together with the patient to adjust together.  Herb also talks about the role of family in health care decisions and motivation.  This presentation provides insight into both the patient and physician perspectives.

Healthcare Disparity – A physician and patient perspective

Dr. Lars Svensson talks with cardiologist Dr. Kapadia and heart surgeon Dr. Gillinov about COVID-19, how it is impacting cardiac care and procedures at Cleveland Clinic and what patients should know when seeking care during this time.

COVID-19 and Your Heart

Steven Nissen, MD, sits down with Marc Gillinov, MD,  Chairman of the Department of Thoracic and Cardiovascular Surgery and Brian Griffin, MD, Section Head Cardiovascular Imaging to discuss the timing of heart surgery, one valve at a time – the differences between aortic and mitral valves and regurgitation and stenosis.  Changes in diagnostic imaging techniques, surgical and interventional options, as well as looking at outcomes data have changed the way we look at these patients and timing of intervention.

Valve Disease:  When is the right time to intervene?

Dr. Venu Menon, Director of the Cardiovascular Fellowship Program and Section Head, Clinical Cardiology discusses with Erika Hutt, MD a first year cardiovascular fellow the use of the WATCHMAN, a left atrial appendage closure device, in patients with prior intracranial hemorrhage.  Her study was recently published in Heart Rhythm.   Drs. Menon and Hutt talk about the study, the patient population as well as the findings and what this means for this patient population in the future.

Left atrial appendage closure device implantation in patients with prior intracranial hemorrhage

Richard Grimm, DO, Director of the Echocardiography Laboratory, and Helga Lombardo, RDCS, FASE Supervisor, Echocardiography Lab, discuss many aspects of running a successful high volume echo lab.

Echo Lab: Managing Quality, Productivity, Efficiency and Innovation

Kate Patton, Med, RD, CCSD, LD, Preventive Cardiology and athlete nutrition expert from our Sports Cardiology Center discusses the impact of supplements and energy drinks on cardiovascular health and athletic performance and foods that provide sports performance benefits.

Nutrition, Supplements and Energy Drinks:  Implications for Cardiac Care of the Athlete

Dr. Erik Van Iterson, Director of Cardiac Rehabilitation at Cleveland Clinic describes the benefits of cardiac rehabilitation for various patient populations, current enrollment statistics, factors that play into enrollment, tips for health care providers, what is included in cardiac rehab and new trends in cardiac rehabilitation programming.

What you should know about cardiac rehabilitation

Dr. Miriam Jacob discusses pulmonary hypertension with cardiac surgeon Dr. Michael Tong and pulmonologist Dr. Gustavo Heresi.  Many topics are discussed including the complexity of evaluation and diagnosis, a review of the World Symposium on Pulmonary Hypertension recommendations and what this means for diagnosis thresholds, approaches to medical therapy, surgery for those who have chronic thromboembolic pulmonary hypertension (CTEPH), balloon pulmonary angioplasty (BPA), and when lung transplant is considered.  The pulmonary hypertension team approach at Cleveland Clinic is described as well as current research studies.

Pulmonary Hypertension: What clinicians should know – panel of experts

Dr. Lee Kirksey, Vascular Surgeon and Vice Chairman of Vascular Surgery and Dr. Sean Lyden, MD, Chairman, Department of Vascular Surgery at Cleveland Clinic’s Sydell and Arnold Miller Family Heart &amp; Vascular Institute discuss the changes in operative strategies for aortic aneurysm repair.  As the national trend shows an increase in EVAR and decline in open repair, is it time to review current training programs to see if there is a need for specialized training in complex open aortic repair in high volume centers?

Vascular Surgery:  Impact of national trends on surgeon training

Dr. Mazen Hanna describes the findings of ATTR-ACT, a study aimed at the treatment of transthyretin (TTR) amyloid cardiomyopathy with the medication tafamadis.  Those who were treated with the medication had reduced mortality, hospitalizations, and better functional capacity and quality of life.  This is an exciting new breakthrough for patients with TTR amyloidosis.

Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy

Dr. Steven Nissen, Chief Academic Officer, Chief Academic Officer, Sydell and Arnold Miller Family Heart &amp; Vascular Institute discusses the latest techniques in treatment of total coronary total occlusion (CTO) with Dr. Jaikirshan(Jay) Khatri, specialist in CTO care.  Dr. Khatri reviews patient selection – who would benefit most from this treatment,  including diagnostic testing, clinical and diagnostic criteria; describes interventional techniques such as use of retrograde collaterals and advanced antegrade techniques and how stents are used during these procedures;  reviews outcomes and risks of interventional procedures for chronic coronary occlusion; and discusses current research .

Chronic Coronary Total Occlusion

Dr. Stephen Ellis, Interventional Cardiologist at Cleveland Clinic takes us through the results of the International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA Trial) and provides key take-aways from the results.

ISCHEMIA Trial – Will this change clinical practice?

Luke Laffin, MD, Medical Director of Cardiac Rehabilitation and cardiologist in the Section of Preventive Cardiology at Cleveland Clinic talks about two related abstracts recently presented at the American Heart Association’s Hypertension Scientific Sessions focused on resistant hypertension in a cardiac rehabilitation program.  Dr. Laffin defines resistant hypertension, the prevalence of resistant hypertension in a cardiac rehabilitation setting, factors associated with patients who have resistant hypertension, and lessons learned about this patient population.

Resistant Hypertension and Cardiac Rehabilitation

Dr. Venu Menon, Director of the Cardiac Intensive Care Unit and the Cardiovascular Fellowship Program talks with Dr. Anirudh Kumar, a second year cardiovascular fellow about his recent research related to two high risk populations of STEMI patients, those with cardiogenic shock and those who present with cardiac arrest who underwent PCI.  The findings were shared related to short and long-term outcomes in these two patient populations.   In addition, he describes how and if new STEMI protocols had an impact on these high risk patients.

STEMI Outcomes in High Risk Populations

Dr. Lee Kirksey, Vascular Surgeon and Vice Chairman of Vascular Surgery talks with Dr. David Hardy, Department of Vascular Surgery and Dr. Tushar Vachharajany, Nephrology and Hypertension about the challenges of dialysis access.  Topics include vascular access at Cleveland Clinic, what should go into the planning and implementation of vascular access, approaches to decrease catheter exposure, graft types,  the multidisciplinary care of dialysis patients, many who have cardiovascular and kidney disease, challenges of management and care of patients who have urgent needs.

Vascular Surgery – Dialysis Access Expert Panel

The best podcast episodes on global issues affecting everyone. Covering topics such as the #metoo movement, climate change, the impact of technology and some of the biggest global issues facing us right now. For anyone interested in learning more about the world, and some of the issues we're facing, pick an episode below and start listening! Add episodes you're interested into your queue below!

Best Episodes on Global Issues

The Best Multi-Part Documentaries, with documentaries on Obama, Federer vs Nadal, the making of Star Wars, Netflix vs Blockbuster and more. Add episodes you're interested into your queue below!